The metabolic syndrome and its individual components: Its association with venous thromboembolism in a mediterranean population

Metabolic Syndrome and Related Disorders

Volumn 9, Issue 3, 2011, Pages 197-201

  Vayá, Amparo ^a   Martínez Triguero, María L ^a   España, Francisco ^a   Todolí, José A ^a   Bonet, Elena ^a   Corella, Dolores ^b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; CARDIOLIPIN ANTIBODY; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S;

ABDOMINAL OBESITY; ADULT; ANALYSIS; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; PLASMA VISCOSITY; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK; SOUTHERN EUROPE; THROMBOPHILIA; TOBACCO;

ADULT; BODY MASS INDEX; BODY WEIGHTS AND MEASURES; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIPIDS; MALE; MEDITERRANEAN REGION; METABOLIC SYNDROME X; MIDDLE AGED; POPULATION; PREVALENCE; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 79957651373     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2010.0117     Document Type: Article

References (26)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
2. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement: Executive Summary. Circulation 2005;112:2735-2752. (Pubitemid 41532612)
3. Opie LH. Metabolic syndrome. Circulation 2007;115:e32-e35. (Pubitemid 46148516)
4. Gami AS, Witt BJ, Howard DE, Erwin Pj, Gami LA, Somers VK, Montori VM. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-414. (Pubitemid 46135879)
5. Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, Mannarino E. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 2004;43:1817-1822. (Pubitemid 38622521)
6. Franchini M, Lippi G, Manzato F, Vescovi PP, Targher G. Hemostatic abnormalities in endocrine and metabolic disorders. Eur J Endocrinol 2010;162:430-451.
7. Ageno W, Dentali F, Grandi Am. New evidence on the potential role of the metabolic syndrome as a risk factor for venous thromboembolism. J Thromb Haemost 2009;7:736-738.
8. Ageno W, Prandoni P, Romualdi E, Ghirarduzzi A, Dentali F, Pesavento R, Crowther M, Venco A. The metabolic syndrome and the risk of venous thrombosis: A case control study. J Thromb Haemost 2006;4:1914-1918. (Pubitemid 44226768)
9. Ay C, Tengler T, Vormittag R, Simanek R, Dorda W, Vukovich T, Pabinger I. Venous thromboembolism- a manifestation of the metabolic syndrome. Haematologica 2007;92:374-380. (Pubitemid 350143547)
10. Ambrosetti M, Ageno W, Salerno M, Pedretti RF, Salerno- Uriarte JA. Metabolic syndrome as a risk factor for deep vein thrombosis after acute cardiac conditions. Thromb Res 2007;120:815-818. (Pubitemid 47418237)
11. Jang MJ, Choi WI, Bang SM, Lee T, Kim YK, Ageno W, Oh D. Metabolic syndrome is associated with venous thromboembolism in the Korean population. Arteriosclerosis Thromb Vas Biol 2009;29:311-315.
12. Alessi MC, Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost 2008;99:995-1000. (Pubitemid 351810479)
13. Ray JG, Lonn E, Yi Q, Yusuf S, Arnold MJ, McQueen MJ, Pogue J, Probstfield J, Fodor G, Held C, Micks M, Genest Jr. Venous thromboembolism in association with features of the metabolic syndrome. QJM 2007;100:679-684. (Pubitemid 350042428)
14. Steffen LM, Folsom AR, Cushman M, Jacobs DR Jr, Rosamond WD. Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology. Circulation 2007;115:188-195. (Pubitemid 46105717)
15. Borch KH, Brkkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen JB. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø study. J Thromb Haemost 2009;7:739-745.
16. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005;366:1059-1062. (Pubitemid 41338752)
17. Steffen LM, Cushman M, Peacock JM, Heckbert SR, Jacobs DR Jr, Rosamond WD, Folsom AR. Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 2009;7:746-751.
18. Cornier MA, Dabelea D, Hernández TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH. The metabolic syndrome. Endocr Rev 2008;29:777-822.
19. Scuteri A, Najjar SS, Morrell CH, Lakatta EG. Cardiovascular Health Study. The metabolic syndrome in older individuals; prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care 2005;28: 882-887. (Pubitemid 40434490)
20. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethhon MR, Heymsfield SB. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-436. (Pubitemid 36241019)
21. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, Whelton PK, He J. InterASIA Collaborative Group. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005;365:1398-1405. (Pubitemid 40523734)
22. Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 1996;143:1257-1265. (Pubitemid 26178738)
23. Jung F, Roggenkamp HG, Scheider R, Kiesewetter H. Das Kapillarschlauch-Plasmaviskosimeter ein neues Messgerä t zur Quantifizierung der Blutplasmaviskositä t. Biomedizinische Technik (Berlin) 1983;28:249-252.
24. VayáA, Mira Y, Mateo J, FalcóC, Villa P, Estellés A, Corella D, Fontcuberta J, Aznar J. Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk. Thromb Haemost 2003;89:452-457. (Pubitemid 36329234)
25. Laporte S, Mismetti P. Epidemiology of thrombotic risk factors: The difficulty in using clinical trials to develop a risk assessment model. Crit Care Med 2010;38(2 Suppl):S10-S17.
26. Borch KH, Brkkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen JB. Anthropometric measures of obesity and risk of venous thromboembolism: The Tromso study. Arterioscler Thromb Vas Biol 2010;30:121-127.